TCS calls for a tough restructure : Plans 2% workforce reduction in FY26 Says CEO

Date:

Share post:

TCS calls for a tough restructure : Plans 2% workforce reduction in FY26 Says CEO

PharmaGenDrx News Bureau28th July, 2025

“One of the toughest decisions I have had to take as CEO”, Tata Consultancy Services (TCS) CEO K. Krithivasan said in a recent interview. TCS, India’s largest IT services firm is set to implement a measured restructuring of its workforce, in the financial year 2026 (Y26). At present, around 6,13,000 people are employed in the company as of Q1 FY 2026; therefore, about 12,200 people will be laid off as per the source, stating 2% reduction of its total workforce.

The CEO defends this initiative, expressing the need and commitment to being agile and future-ready, focusing on growth and internal mobility. Employees at a significantly primary level remain absolutely guarded from this fundamental shift, as this reduction targets middle and senior management positions. It was emphasised that the entire process of re-structuring would be handled with utmost care, especially to ensure that both clients and affected employees face little to no adversities.

The laid-off employees are said to have been receiving a notice period compensation, three months severance pay, along with outplacement opportunities to ensure a respectful and supportive transition. CEO K. Krithivasan acknowledged the constraints in harmonizing  existing  roles with the ever-evolving  demands of dynamic enterprise priorities.

This organizational realignment follows economic uncertainty and a quest to optimize the marginal profits. This move is now said to fuel the other industries to do the same, following TCS’s footsteps. TCS has also delayed employing the lateral hires who have already received an offer letter in recent months. Along with this, RMG of TCS had announced the New Billability Policy, according to which, an employee must have 225 billable days and only be allowed 35 days of benching, to aim towards more productivity and client satisfaction.

The CEO also added that this step towards re-modelling was initiated to prevent decision-making delays, ensuring the company’s productivity by continuous meaningful project opportunities, professional growth benefits and value-driven recognition.

By Arundhuti Chatterjee & Sharon Bose

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...